<?xml version="1.0" encoding="UTF-8"?>
<p>The clinical manifestations of SARS-CoV-2 are uncertain and change frequently. Some infections are asymptomatic. Symptoms can include respiratory distress syndrome, pneumonia of different levels of severity,
 <sup>
  <xref rid="bibr67-0300060520949077" ref-type="bibr">67</xref>
 </sup> and sometimes death. According to the WHO, the most common symptoms of COVID-19 are fever, fatigue, dry continuous cough, and shortness of breath.
 <sup>
  <xref rid="bibr68-0300060520949077" ref-type="bibr">68</xref>,
  <xref rid="bibr69-0300060520949077" ref-type="bibr">69</xref>
 </sup> Some patients may have a runny nose, sore throat, nasal congestion, aches and pains, and diarrhea.
 <sup>
  <xref rid="bibr70-0300060520949077" ref-type="bibr">70</xref>
 </sup> Some patients report a loss of sense of smell and taste.
 <sup>
  <xref rid="bibr71-0300060520949077" ref-type="bibr">71</xref>
 </sup> In some cases, symptoms are mild and similar to those of the common cold; in such patients, recovery can occur without any treatment.
 <sup>
  <xref rid="bibr72-0300060520949077" ref-type="bibr">72</xref>
 </sup> The least commonly observed symptoms include nausea or vomiting, coughing up blood or bloody mucus, and viral conjunctivitis causing red eyes, watery discharge from the eyes, swollen eyelids and light sensitivity.
 <sup>
  <xref rid="bibr3-0300060520949077" ref-type="bibr">3</xref>
 </sup> Occasional upper respiratory and gastrointestinal symptoms, accompanied by changes vital signs such as increased respiration (heart rate) and low blood pressure may also be observed, especially in the elderly and among individuals suffering from heart disease, chronic respiratory conditions and diabetes.
 <sup>
  <xref rid="bibr73-0300060520949077" ref-type="bibr">73</xref>
 </sup> Additionally, patients critically ill with COVID-19 may present with increased venous thromboembolism including thrombocytopenia, elevated D-dimer, prolonged prothrombin time and disseminated intravascular coagulation (DIC). These coagulation abnormalities are associated with a systemic inflammatory response and an imbalance between pro-coagulant and anticoagulants homeostasis mechanisms. and increase the risk of mortality.
 <sup>
  <xref rid="bibr74-0300060520949077" ref-type="bibr">74</xref>
 </sup> Some of these clinical features are also observed in cases of DIC observed in septic patients. These features are very distinct in COVID-19 patients as their levels are higher than the standards for sepsis.
 <sup>
  <xref rid="bibr75-0300060520949077" ref-type="bibr">75</xref>,
  <xref rid="bibr76-0300060520949077" ref-type="bibr">76</xref>
 </sup>
</p>
